Word: portioning
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...Israel's chief benefactor, Washington has become an increasingly uncomfortable hostage of the Lavi affair. While the U.S. Government gives Israel $1.8 billion a year in military assistance -- far more than to any other country -- the Lavi claims an ever growing portion of that aid. Washington has so far provided most of the $1.8 billion that Israelis have spent to develop the Lavi and build two prototypes since 1979. But that is just the beginning: development costs that were estimated at $800 million when the project began could reach at least $2.75 billion by the time the first...
Despite workers' complaints, though, only a portion of the country's increased productivity can be chalked up to more intense toil. Much of the gain results from the scrapping of obsolete plants and the installing of improved technology. Says Stanley Mihelick, Goodyear's executive vice president for worldwide production: "The mistake that people make is that all of this productivity is because workers are sweating more. Hell, no. It comes from our $1.5 billion investment in new plant and equipment...
...were kept secret.) Several legislators believe the number of known findings is more than in any previous Administration. More important, the operations have grown steadily in size, importance and cost. Covert operations, says Anthony Beilenson, a California Democrat who sits on the House Intelligence Committee, are a "much bigger portion of the foreign policy pie than ever before...
...ethical lapses in officials in government, finance, religion and the military. You point a finger at businessmen, educators, physicians, lawyers and almost every other segment of our society except publishers and editors. If you spent time researching your own profession, you would surely find an equivalent or even larger portion of it involved in the same activities you condemn in other fields...
Peptide T, another promising substance for curbing the virus, received mixed reviews. Last December, Neuroscientist Candace Pert of the National Institute of Mental Health reported that the chemical, a synthetic portion of a protein on the AIDS virus that helps it bind to cells, seemed to prevent the virus from entering cells. In May the FDA approved clinical trials, and last week Oncogen, a Seattle biotechnology company, announced that its researchers had confirmed Pert's findings. But Dr. William Haseltine, a virologist at Harvard's Dana Farber Cancer Institute, said neither his laboratory nor six others around the world...